Sysmex
Logotype for Sysmex Corporation

Sysmex (6869) investor relations material

Sysmex Q1 2027 earnings summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Sysmex Corporation
Q1 2027 earnings summary7 Aug, 2026

Executive summary

  • Net sales for the first quarter rose to ¥130.6 billion, up 23.6% year-on-year, with operating profit at ¥14.8 billion, up 39.5%, and profit attributable to owners at ¥8.6 billion, up 90.9%, driven by strong growth in the Americas, Japan, and yen depreciation.

  • Significant sales growth in hematology, especially in the Americas, and solid performance in EMEA and AP regions; China declined 33.8% as forecast.

  • Higher profits resulted from increased sales and the elimination of prior-year one-time inventory revaluation factors.

  • Cash flows from operating activities reached ¥35.5 billion, with free cash flow at ¥17.0 billion, both showing substantial year-over-year increases.

  • SG&A and R&D expenses increased due to business expansion but remained under control.

Financial highlights

  • Operating margin improved to 11.3%, up 1.2 percentage points year-on-year, with cost of sales at ¥64.3 billion (49.3% of sales), SG&A at ¥42.6 billion (32.6%), and R&D at ¥7.2 billion (5.5%).

  • Profit attributable to owners margin rose to 6.7% from 4.3% year-on-year.

  • Basic EPS increased to ¥14.17 from ¥7.30 year-on-year.

  • Cash and cash equivalents increased by ¥29,517 million to ¥113,634 million.

  • Exchange rates: 1 USD = ¥159.3, 1 EUR = ¥185.3, 1 CNY = ¥23.4.

Outlook and guidance

  • First-half forecast revised upward: net sales ¥265.0 billion (+14.0% YoY), operating profit ¥25.0 billion, profit attributable to owners ¥15.0 billion, reflecting strong Americas performance and FX trends.

  • Full-year forecast: net sales ¥545.0 billion (+9.0% YoY), operating profit ¥60.0 billion (+15.8%), profit attributable to owners ¥37.0 billion (+4.4%), with interim dividend forecast raised to ¥20.00 per share and annual to ¥40.00 per share.

  • One-time expenses related to a business review may be incurred in Q2 and are factored into forecasts.

  • China sales expected to decline 20% year-on-year for the full year, with gradual easing of negative impacts in the second half.

  • Guidance may be updated pending regulatory and business developments in China.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
Research faster. Power your platform.

Next Sysmex earnings date

Logotype for Sysmex Corporation
Q2 202711 Nov, 2026
Sysmex
Cover every name on your watchlist this earnings season.
Automations, AI chat, and live calls across 16,000+ companies.
Book demo

Next Sysmex earnings date

Logotype for Sysmex Corporation
Q2 202711 Nov, 2026

AI chat

Ask anything. Verify everything.

Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn more

Find what matters

AI across all first-party IR material. Live calls, transcripts, slides, filings.
A cited source card from Adobe's CFO alongside a list of forward-looking statements

Trust every finding

50m+ first-party documents. Every output traceable to its source.

Automations

Zero in on what matters

Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more
An automation set to trigger on the first published earnings document for GE Aerospace

Event-triggered research

Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.
An automation scheduled to run weekly on Mondays at 09:00

Scheduled research

Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.

Live audio & transcripts

Be first

Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more
A live LVMH Q2 2026 earnings call playing in Quartr

Live earnings calls

Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.
A live transcript excerpt from LVMH's Chairman and CEO Bernard Arnault

Live transcripts

Speaker-by-speaker, in real time. Searchable across every live and historical call.

Quartr MCP connects your AI environment to 17K+ public companies

Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more

Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.

Jamie Ross

Investment Manager, GAM Investments

GAM
GAM

Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.

Tom O'Hara

Investment Director

Ciena
Ciena

Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.

Gregg Lampf

VP of Investor Relations

Frequently asked questions

Sysmex Corporation is a Japanese company in the healthcare sector, primarily engaged in the development, manufacture, and sales of diagnostic instruments, reagents, and health management support software. Founded in 1968, as TOA Medical Electronics, it later adopted the Sysmex brand in 1978, initially focusing on haematology analysers before expanding its product range. Sysmex's solutions encompass haematology, haemostasis, and urinalysis analyzers, with research and development centers in Japan, France, New Zealand, Germany, and the US. The company is headquartered in Kobe, Japan, and its shares are listed on the Tokyo Stock Exchange.